Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	833,407	285,738	293,298	312,699	493,057	331,408
Market Cap Growth	201.50%	-2.58%	-6.20%	-36.58%	48.78%	60.94%
Enterprise Value	948,206	384,979	380,259	385,923	578,014	375,012
Last Close Price	63800.00	23000.00	25700.00	27400.00	43250.00	29050.00
PE Ratio	49.43	-	-	146.58	-	-
Forward PE	-	30.73	30.73	30.73	30.73	30.73
PS Ratio	3.95	1.77	2.35	1.94	2.98	2.56
PB Ratio	2.41	1.91	2.13	1.86	4.96	5.72
P/TBV Ratio	2.41	1.92	2.13	1.88	5.03	5.86
P/OCF Ratio	55.98	-	-	-	-	-
PEG Ratio	-	94.42	94.42	94.42	94.42	94.42
EV/Sales Ratio	4.49	2.38	3.05	2.39	3.49	2.90
EV/EBITDA Ratio	35.32	-	-	31.87	37.17	-
EV/EBIT Ratio	55.75	-	-	146.09	136.03	-
EV/FCF Ratio	-66.49	-	-	-	-	-
Debt / Equity Ratio	0.35	0.85	0.78	0.44	0.69	1.33
Debt / EBITDA Ratio	4.56	-	-	6.10	4.43	-
Net Debt / Equity Ratio	0.33	0.76	0.73	0.40	0.41	1.07
Net Debt / EBITDA Ratio	4.28	-8.64	-6.57	5.58	2.64	-4.84
Net Debt / FCF Ratio	-8.05	-5.12	-2.86	-2.49	-1.99	-6.17
Asset Turnover	0.43	0.44	0.40	0.59	0.69	0.49
Inventory Turnover	3.08	2.53	1.65	2.18	2.89	2.81
Quick Ratio	0.24	0.24	0.26	0.33	0.51	0.26
Current Ratio	0.56	0.50	0.82	1.01	1.03	0.69
Return on Equity (ROE)	7.75%	-64.87%	-22.00%	3.01%	-1.75%	-54.34%
Return on Assets (ROA)	2.16%	-3.79%	-4.83%	0.60%	1.10%	-6.13%
Return on Invested Capital (ROIC)	3.93%	-8.81%	-10.18%	1.37%	3.26%	-18.53%
Return on Capital Employed (ROCE)	3.70%	-10.40%	-13.30%	1.30%	3.10%	-25.00%
Earnings Yield	2.14%	-32.58%	-10.48%	0.68%	-0.28%	-13.03%
FCF Yield	-1.71%	-7.80%	-11.94%	-8.69%	-4.18%	-3.03%
Buyback Yield / Dilution	-18.03%	-4.65%	9.69%	-10.85%	-	0.01%
Total Shareholder Return	-18.03%	-4.65%	9.69%	-10.85%	-	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.